2022 CVS Caremark DOAC non-medical switch: Patient ramifications and physician advocacy
Saved in:
| Main Authors: | Kushal D. Patel, Dharmesh Patel, Hunt Deison, Ryan Gough |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | American Journal of Preventive Cardiology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667724002381 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of DOACS and DOAC-REMOVE® on coagulation assays during thrombophilia testing in DOAC-treated patients
by: Kovač Mirjana, et al.
Published: (2022-01-01) -
Specialist physician perspectives on non-medical switching of prescription medications
by: Olivia S. Costa, et al.
Published: (2020-01-01) -
Flickering in CVs and Accretion Disc Viscosity
by: R. Baptista
Published: (2015-02-01) -
CVs Around the Minimum Orbital Period
by: S. Zharikov, et al.
Published: (2015-02-01) -
Characteristics of chronic subdural haematomas related to DOACs vs warfarin
by: Gokul Raj Krishna, et al.
Published: (2025-04-01)